<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21939" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Fournier Gangrene</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Leslie</surname>
            <given-names>Stephen W.</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rad</surname>
            <given-names>Jonathan</given-names>
          </name>
          <aff>Wellstar Kennestone</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Foreman</surname>
            <given-names>Juron</given-names>
          </name>
          <aff>Wellstar Kennestone Regional Med. Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Stephen Leslie declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jonathan Rad declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Juron Foreman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>5</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21939.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Fournier gangrene, a relatively rare form of necrotizing fasciitis, is a rapidly progressive disease that affects the deep and superficial tissues of the perineal, anal, scrotal, and genital regions. The disease is one of the few urological emergencies and requires prompt surgical debridement as well as antibiotic therapy. This activity reviews the evaluation and treatment and highlights the role of the healthcare team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of Fournier gangrene.</p></list-item><list-item><p>Describe the typical presentation of patients suffering from Fournier gangrene.</p></list-item><list-item><p>Identify the treatment and management of Fournier gangrene.</p></list-item><list-item><p>Explain interprofessional team strategies for improving care coordination and communication to advance Fournier gangrene and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21939&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21939">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21939.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Fournier gangrene, a relatively rare form of necrotizing fasciitis, is a rapidly progressive disease that affects the deep&#x000a0;and superficial tissues of the perineal, anal, scrotal, and genital regions. Named after Dr. Alfred Fournier, the French dermatology&#x000a0;and venereal specialist, it was initially described in 1883 as necrotizing fasciitis of the external genitalia, perineal, and perianal region in five of Dr. Fournier&#x02019;s patients.<xref ref-type="bibr" rid="article-21939.r1">[1]</xref><xref ref-type="bibr" rid="article-21939.r2">[2]</xref>&#x000a0;Also known as necrotizing fasciitis, the disease involves the rapid spread of severe inflammatory and infectious processes along fascial planes affecting adjacent soft tissue; therefore, the disease may initially go unnoticed or unrecognized as there may be minimal or no skin manifestations in its early stages.<xref ref-type="bibr" rid="article-21939.r2">[2]</xref><xref ref-type="bibr" rid="article-21939.r3">[3]</xref>&#x000a0;</p>
        <p>Fournier gangrene is often associated with general signs of sepsis, rapid tissue destruction, and a high fatality rate of 40%.<xref ref-type="bibr" rid="article-21939.r4">[4]</xref><xref ref-type="bibr" rid="article-21939.r5">[5]</xref>&#x000a0;The spread of inflammation and infection leads to thrombosis of blood vessels, which in turn causes ischemia and tissue necrosis of the adjacent soft tissue and fascia.<xref ref-type="bibr" rid="article-21939.r6">[6]</xref> The infectious&#x000a0;and inflammatory process spreads quickly along the Dartos, Colles, and Scarpa&#x02019;s fascias, allowing for the early involvement of the abdominal wall.<xref ref-type="bibr" rid="article-21939.r6">[6]</xref>&#x000a0;Due to initial fascial&#x000a0;and subcutaneous involvement, clinicians can miss this disease in its early stages because the overlying soft tissue can often look unremarkable or appear as simple cellulitis.<xref ref-type="bibr" rid="article-21939.r7">[7]</xref><xref ref-type="bibr" rid="article-21939.r8">[8]</xref>&#x000a0;Early diagnosis and treatment of this potentially fatal disease are key as it can easily get misdiagnosed initially as an otherwise benign process.<xref ref-type="bibr" rid="article-21939.r2">[2]</xref><xref ref-type="bibr" rid="article-21939.r3">[3]</xref><xref ref-type="bibr" rid="article-21939.r8">[8]</xref><xref ref-type="bibr" rid="article-21939.r9">[9]</xref><xref ref-type="bibr" rid="article-21939.r10">[10]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-21939.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>This disease process results from polymicrobial aerobic and anaerobic synergistic infection of the fascia and subcutaneous soft tissue. Gram-positive bacteria such as <italic toggle="yes">Group A Streptococci </italic>and <italic toggle="yes">Staphylococcus aureus</italic>&#x000a0;and gram-negative bacteria such as <italic toggle="yes">E. Coli </italic>and <italic toggle="yes">Pseudomonas aeruginosa </italic>are organisms most commonly grown in wound cultures of Fournier gangrene patients as it is usually polymicrobial.<xref ref-type="bibr" rid="article-21939.r11">[11]</xref><xref ref-type="bibr" rid="article-21939.r12">[12]</xref>&#x000a0;These bacteria can be introduced through several sources, including urinary, bowel, or dermal. Urinary tract infections&#x000a0;and other infectious processes of the perineum, such as perianal abscesses or even a simple pimple, may also provide a starting point for the infection.<xref ref-type="bibr" rid="article-21939.r6">[6]</xref>&#x000a0;</p>
        <p>Surgical manipulation of the genital&#x000a0;and perineal area similarly can provide the initial insult required to develop Fournier gangrene.<xref ref-type="bibr" rid="article-21939.r6">[6]</xref><xref ref-type="bibr" rid="article-21939.r7">[7]</xref>&#x000a0;Any traumatic insult or localized area of skin breakdown to the perineum or scrotum can lead to bacterial access to the subcutaneous tissues and begin the process, ultimately resulting in Fournier gangrene.<xref ref-type="bibr" rid="article-21939.r3">[3]</xref><xref ref-type="bibr" rid="article-21939.r13">[13]</xref><xref ref-type="bibr" rid="article-21939.r14">[14]</xref><xref ref-type="bibr" rid="article-21939.r15">[15]</xref>&#x000a0;About 25% of cases had no known or identifiable etiology.<xref ref-type="bibr" rid="article-21939.r16">[16]</xref></p>
      </sec>
      <sec id="article-21939.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Fournier gangrene is a rare infection that constitutes &#x0003c;0.02% of all hospital admissions. It has a strong predilection for males as opposed to females, with a 10 to 1 ratio. The incidence in males is 1.6 cases per 100,000 men.<xref ref-type="bibr" rid="article-21939.r12">[12]</xref><xref ref-type="bibr" rid="article-21939.r17">[17]</xref>&#x000a0;Fournier gangrene is seen most commonly in men ages 50&#x000a0;to 79, with an incidence of 3.3 cases per 100,000 men.<xref ref-type="bibr" rid="article-21939.r12">[12]</xref><xref ref-type="bibr" rid="article-21939.r17">[17]</xref>&#x000a0;The southeastern United States has the highest reported rate of Fournier gangrene at 1.9 cases per 100,000 population.<xref ref-type="bibr" rid="article-21939.r18">[18]</xref> These frequencies appear relatively constant in all patients in the US and worldwide.<xref ref-type="bibr" rid="article-21939.r18">[18]</xref>&#x000a0;</p>
        <p>While less common in females, women tend to be more acutely ill at presentation, are twice as likely to require mechanical ventilation and dialysis, have a longer average length of hospitalization, and have a higher fatality rate than male patients.<xref ref-type="bibr" rid="article-21939.r18">[18]</xref></p>
        <p>While Fournier gangrene can appear in healthy individuals (26% to 30%), it is typically associated with a debilitated or immunocompromised state. It is most commonly seen in male diabetics over 50 years of age who have a history of alcohol abuse.<xref ref-type="bibr" rid="article-21939.r5">[5]</xref><xref ref-type="bibr" rid="article-21939.r19">[19]</xref>&#x000a0; Patients with multiple comorbidities tend to have worse outcomes.<xref ref-type="bibr" rid="article-21939.r5">[5]</xref></p>
        <p>Known risk factors for Fournier gangrene include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Atherosclerosis</p>
          </list-item>
          <list-item>
            <p>Chemotherapy<xref ref-type="bibr" rid="article-21939.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>Chronic alcohol abuse (25% to 50% of cases)</p>
          </list-item>
          <list-item>
            <p>Chronic steroid use</p>
          </list-item>
          <list-item>
            <p>Colorectal malignancy</p>
          </list-item>
          <list-item>
            <p>Diabetes (20% to 70% of cases)<xref ref-type="bibr" rid="article-21939.r20">[20]</xref></p>
          </list-item>
          <list-item>
            <p>Drug abuse (especially if injected directly into inguinal veins or the penis)</p>
          </list-item>
          <list-item>
            <p>HIV infection<xref ref-type="bibr" rid="article-21939.r21">[21]</xref></p>
          </list-item>
          <list-item>
            <p>Immunosuppression</p>
          </list-item>
          <list-item>
            <p>Inflammatory bowel disease</p>
          </list-item>
          <list-item>
            <p>Leukemia<xref ref-type="bibr" rid="article-21939.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p>Liver failure, cirrhosis</p>
          </list-item>
          <list-item>
            <p>Male gender (90% of cases)</p>
          </list-item>
          <list-item>
            <p>Malnutrition</p>
          </list-item>
          <list-item>
            <p>Neurogenic bladder<xref ref-type="bibr" rid="article-21939.r22">[22]</xref></p>
          </list-item>
          <list-item>
            <p>Obesity</p>
          </list-item>
          <list-item>
            <p>Perianal abscess</p>
          </list-item>
          <list-item>
            <p>Peripheral vascular disease</p>
          </list-item>
          <list-item>
            <p>Prostate cancer</p>
          </list-item>
          <list-item>
            <p>Recent trauma or surgery (prostate biopsy, catheterization, cystoscopy)<xref ref-type="bibr" rid="article-21939.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p>Rectal fistula</p>
          </list-item>
          <list-item>
            <p>Renal failure</p>
          </list-item>
          <list-item>
            <p>Significant cardiac disease<xref ref-type="bibr" rid="article-21939.r24">[24]</xref></p>
          </list-item>
          <list-item>
            <p>Spinal cord injury</p>
          </list-item>
          <list-item>
            <p>Urethral strictures</p>
          </list-item>
          <list-item>
            <p>Use of sodium-glucose cotransporter 2 inhibitors (glycosuric medications used in patients with diabetes)<xref ref-type="bibr" rid="article-21939.r25">[25]</xref></p>
          </list-item>
        </list>
        <p>Despite the worldwide advances in treating sepsis, the mortality rate for Fournier gangrene has generally remained stable at 40%.<xref ref-type="bibr" rid="article-21939.r5">[5]</xref><xref ref-type="bibr" rid="article-21939.r26">[26]</xref><xref ref-type="bibr" rid="article-21939.r27">[27]</xref>&#x000a0;A significant contributor to this alarmingly high mortality rate is the delay in diagnosis and treatment, which can increase the mortality rate to 88%.<xref ref-type="bibr" rid="article-21939.r11">[11]</xref><xref ref-type="bibr" rid="article-21939.r19">[19]</xref><xref ref-type="bibr" rid="article-21939.r27">[27]</xref>&#x000a0;The single most critical factor affecting mortality is the time until surgical intervention, as early surgery can reduce the death rate by one-half!<xref ref-type="bibr" rid="article-21939.r11">[11]</xref><xref ref-type="bibr" rid="article-21939.r28">[28]</xref><xref ref-type="bibr" rid="article-21939.r29">[29]</xref>&#x000a0;Severe diabetes, heart disease, and renal failure significantly increase the mortality rate.<xref ref-type="bibr" rid="article-21939.r16">[16]</xref></p>
      </sec>
      <sec id="article-21939.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of Fournier gangrene involves a synergistic infectious process involving anaerobic and aerobic bacteria. The bacterial infection starts with an initial insult such as a urinary tract infection, perineal abscess, localized cellulitis, recent surgical manipulation of the genital or perineal area, or even a simple scratch or pimple. The synergistic activity of the bacterial infection leads to bacterial production of tissue-destructive enzymes, collagenases, and endotoxins, causing obliterative endarteritis with micro thromboses of subcutaneous vessels.<xref ref-type="bibr" rid="article-21939.r30">[30]</xref><xref ref-type="bibr" rid="article-21939.r31">[31]</xref>&#x000a0;This ultimately causes ischemic gangrene of the involved structures&#x000a0;and rapid spread of the infection to adjacent and surrounding tissues.<xref ref-type="bibr" rid="article-21939.r30">[30]</xref><xref ref-type="bibr" rid="article-21939.r31">[31]</xref>&#x000a0;The infectious process can spread as fast as one inch every hour!<xref ref-type="bibr" rid="article-21939.r32">[32]</xref></p>
      </sec>
      <sec id="article-21939.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>While the diagnosis of Fournier gangrene is often predicated on a combination of imaging, history, and physical examination, a biopsy of the area in question is obtainable to differentiate Fournier gangrene from severe cellulitis. The histopathology of Fournier gangrene will show ulceration of the epidermis, neutrophilic exudate, thrombosed vessels, and necrosis.<xref ref-type="bibr" rid="article-21939.r33">[33]</xref></p>
      </sec>
      <sec id="article-21939.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with Fournier gangrene most often present with pain in the perineal or genital area. Since early signs may be minimal or subdued until symptoms become severe, clinicians should be suspicious of any infection or cellulitis in the perineal or scrotal areas, especially if the pain appears out of proportion to the apparent lesion.<xref ref-type="bibr" rid="article-21939.r6">[6]</xref> Infections that appear simple can rapidly progress in severity and produce life-threatening complications. Patients may often report having a medical history of diabetes mellitus, hypertension, malignancy, and/or alcohol abuse; these are all known risk factors for Fournier gangrene as well as being male.<xref ref-type="bibr" rid="article-21939.r14">[14]</xref>&#x000a0;</p>
        <p>Patients may also report being immunocompromised or having recently had trauma to the area as well as recent surgeries. They may report redness and swelling to the perineum, scrotum, and genitals, as well as systemic symptoms such as fever, chills, nausea, vomiting, urinary retention,&#x000a0;and malaise.<xref ref-type="bibr" rid="article-21939.r34">[34]</xref>&#x000a0;</p>
        <p>The earliest signs of a possible Fournier gangrene include itching, localized tenderness, edema, and erythema involving the skin of the perineum, scrotum, or labia.<xref ref-type="bibr" rid="article-21939.r12">[12]</xref>&#x000a0;This can be easily confused with much more common, simple infections such as cellulitis, erysipelas, and impetigo. These more benign infections tend to have sharp, demarcated borders, while Fournier gangrene is more likely to appear with sporadic bulla formation, diffuse edema, and patchy erythema.<xref ref-type="bibr" rid="article-21939.r8">[8]</xref><xref ref-type="bibr" rid="article-21939.r35">[35]</xref>&#x000a0;There may also be evidence of abrasions or possibly even fluctuance, although this is usually found later.<xref ref-type="bibr" rid="article-21939.r21">[21]</xref>&#x000a0;In one study, the most common symptom was scrotal swelling (79%), followed by tachycardia (61%), purulent drainage (60%), crepitus (54%), and fever (41%).<xref ref-type="bibr" rid="article-21939.r36">[36]</xref>&#x000a0;</p>
        <p>While classically considered a male disease, the incidence of Fournier gangrene in women is increasing.<xref ref-type="bibr" rid="article-21939.r36">[36]</xref>&#x000a0;The typical presentation in females is with labial or vulvar cellulitis, with women more likely to be morbidly obese than similarly affected men.<xref ref-type="bibr" rid="article-21939.r36">[36]</xref></p>
        <p>Early diagnosis of Fournier gangrene can be very difficult as 40% of patients may present with no symptoms, and up to 75% of cases are initially misdiagnosed, contributing to its continuing high mortality rate.<xref ref-type="bibr" rid="article-21939.r4">[4]</xref><xref ref-type="bibr" rid="article-21939.r37">[37]</xref><xref ref-type="bibr" rid="article-21939.r38">[38]</xref></p>
        <p>
<bold>Severe Pain Out of Proportion to the Physical Findings is a Classic Finding of Fournier gangrene.</bold>
<xref ref-type="bibr" rid="article-21939.r12">[12]</xref>
</p>
        <p>As the infection progresses, additional features, such as crepitation on palpation, purpura, bulla, and patchy black tissue discoloration, are present.<xref ref-type="bibr" rid="article-21939.r37">[37]</xref>&#x000a0;Subcutaneous gas and crepitus indicate the presence of gas-forming organisms such as clostridia.<xref ref-type="bibr" rid="article-21939.r39">[39]</xref>&#x000a0;The infection will spread following the fascial planes with erythema and tenderness extending into the anterior abdominal wall.<xref ref-type="bibr" rid="article-21939.r40">[40]</xref>&#x000a0;The skin may turn dusky and give off a musty or putrid odor mainly due to anaerobic (usually <italic toggle="yes">Clostridia</italic>) bacterial activity.<xref ref-type="bibr" rid="article-21939.r12">[12]</xref>&#x000a0;</p>
        <p>The area of involvement may spread far beyond the visible margins of the affected skin. Late signs include overt signs of sepsis, shock, hypotension, tachycardia, fever, tachypnea, and organ dysfunction.<xref ref-type="bibr" rid="article-21939.r12">[12]</xref><xref ref-type="bibr" rid="article-21939.r41">[41]</xref>&#x000a0;In severe cases, the infection can spread up to the clavicles.<xref ref-type="bibr" rid="article-21939.r42">[42]</xref>&#x000a0;The testicles, spermatic cord structures, urethra, and corpora cavernosa are usually spared unless they were involved as the original infection source.<xref ref-type="bibr" rid="article-21939.r7">[7]</xref></p>
        <p>While typically an acute, rapidly progressive process, sometimes Fournier gangrene can present much more slowly over days or even weeks. The typical case has been estimated to take about five days from the initial onset of the first symptom to hospital arrival.<xref ref-type="bibr" rid="article-21939.r43">[43]</xref></p>
        <p>The natural history and presentation of Fournier gangrene have been described as five stages:</p>
        <list list-type="bullet">
          <list-item>
            <p>Prodromal symptoms&#x000a0;include lethargy and fever. They may be present from 2 to 7 days.</p>
          </list-item>
          <list-item>
            <p>Genital tenderness and pain. The overlying skin is usually edematous.</p>
          </list-item>
          <list-item>
            <p>Genital pain and tenderness are now intense with increased erythema of the skin.</p>
          </list-item>
          <list-item>
            <p>Subcutaneous crepitation is now present, and the overlying skin appears dusky.</p>
          </list-item>
          <list-item>
            <p>Purulent drainage may be expressed, and there is obvious gangrene involving a portion of the affected area.<xref ref-type="bibr" rid="article-21939.r44">[44]</xref></p>
          </list-item>
        </list>
        <p>Extra attention to the physical examination of the genitalia and perineum is necessary for certain patient groups as these areas are likely to be checked only infrequently. Such patient groups would include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Dementia</p>
          </list-item>
          <list-item>
            <p>Frail and elderly</p>
          </list-item>
          <list-item>
            <p>Morbidly obese<xref ref-type="bibr" rid="article-21939.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Non-verbal<xref ref-type="bibr" rid="article-21939.r45">[45]</xref></p>
          </list-item>
          <list-item>
            <p>Obtunded</p>
          </list-item>
          <list-item>
            <p>Paraplegics</p>
          </list-item>
          <list-item>
            <p>Patients with quadriplegia<xref ref-type="bibr" rid="article-21939.r46">[46]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21939.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of Fournier gangrene may be assisted by a combination of both blood work and imaging, even though the diagnosis is primarily clinical. Clinicians must maintain a high index of suspicion for any inflammatory or infectious process involving the perineum or genitalia, particularly in older male diabetics and others at increased risk.&#x000a0;</p>
        <p>Blood work in suspected Fournier gangrene should include a complete blood count (CBC) with a differential and a comprehensive metabolic panel (CMP). The CBC will often show elevated white blood count (WBC) with the potential for a left shift. The CMP may show electrolyte abnormalities such as&#x000a0;hyponatremia or metabolic acidosis, as well as any concurrent renal failure. Serum lactate, c-reactive protein, and procalcitonin can help evaluate for associated bacteremia&#x000a0;and sepsis.<xref ref-type="bibr" rid="article-21939.r47">[47]</xref> Arterial blood gases may be obtained to assess oxygenation and acid/base status, while blood and wound cultures are necessary to guide antibiotic treatment.<xref ref-type="bibr" rid="article-21939.r48">[48]</xref><xref ref-type="bibr" rid="article-21939.r49">[49]</xref></p>
        <p>While essentially a clinical diagnosis, imaging can aid in confirmation of the disease process and help determine the extent of involvement. However, imaging alone cannot make or rule out the diagnosis of Fournier gangrene and should not delay surgical intervention in hemodynamically unstable patients.<xref ref-type="bibr" rid="article-21939.r50">[50]</xref></p>
        <p><bold>Ultrasound imaging</bold> helps visualize any subcutaneous gas or emphysema in the underlying soft tissue. It can be done quickly, help identify subcutaneous gas before it can be appreciated on physical examination, and is particularly useful in the scrotum. The presence of gas in the scrotum is considered a pathognomonic sign of Fournier gangrene.<xref ref-type="bibr" rid="article-21939.r51">[51]</xref> It&#x000a0;may also be used to evaluate edema, gas, increased subcutaneous fluid, increased vascularity, and thickness of the affected soft tissue.<xref ref-type="bibr" rid="article-21939.r40">[40]</xref><xref ref-type="bibr" rid="article-21939.r52">[52]</xref>&#x000a0;</p>
        <p>Other typical ultrasonographic findings would include "cobblestoning" (individual subcutaneous fat globules surrounded by fluid), the "snow globe" effect (swirling appearance of heterogenous subcutaneous material), and "dirty shadowing" (a hazy appearance of the infected subcutaneous tissue caused by the shadowing effect of gas and reverberation artifacts from hyperechoic foci).<xref ref-type="bibr" rid="article-21939.r12">[12]</xref><xref ref-type="bibr" rid="article-21939.r40">[40]</xref><xref ref-type="bibr" rid="article-21939.r51">[51]</xref><xref ref-type="bibr" rid="article-21939.r52">[52]</xref><xref ref-type="bibr" rid="article-21939.r53">[53]</xref>&#x000a0;This can help differentiate Fournier gangrene from other, more benign infections.<xref ref-type="bibr" rid="article-21939.r52">[52]</xref></p>
        <p><bold>X-ray imaging</bold> of the area may similarly indicate subcutaneous gas in the affected area, which is present in 90% of all Fournier gangrene cases.<xref ref-type="bibr" rid="article-21939.r38">[38]</xref>&#x000a0;Standard X-rays can detect soft tissue gas or emphysema, which will typically follow fascial planes and is visible before crepitus will be detectable on physical examination.<xref ref-type="bibr" rid="article-21939.r12">[12]</xref>&#x000a0;While the finding of subcutaneous emphysema can be helpful, it should not preclude a diagnosis of Fournier gangrene if negative.<xref ref-type="bibr" rid="article-21939.r12">[12]</xref></p>
        <p><bold>Computed tomography (CT) imaging</bold> has shown good sensitivity (88.5%) and specificity (93.3%) for Fournier gangrene.<xref ref-type="bibr" rid="article-21939.r54">[54]</xref>&#x000a0;It is the most sensitive and specific form of imaging in diagnosing Fournier gangrene. Typical findings include fat stranding around affected structures, subcutaneous emphysema, abscess formation, asymmetrical fascial thickening,&#x000a0;and abnormal fluid collections.<xref ref-type="bibr" rid="article-21939.r53">[53]</xref><xref ref-type="bibr" rid="article-21939.r55">[55]</xref><xref ref-type="bibr" rid="article-21939.r56">[56]</xref><xref ref-type="bibr" rid="article-21939.r57">[57]</xref><xref ref-type="bibr" rid="article-21939.r58">[58]</xref>&#x000a0;It is also useful in identifying the source of scrotal gas and excluding various intra- and retroperitoneal disease processes.<xref ref-type="bibr" rid="article-21939.r59">[59]</xref><xref ref-type="bibr" rid="article-21939.r60">[60]</xref>&#x000a0;CT scans are also recommended after surgery to identify new pockets of infection and to assess wound healing.</p>
        <p><bold>MRI scans</bold> are excellent for soft-tissue imaging but are not recommended for the initial diagnosis of suspected Fournier gangrene due to the prolonged imaging time required as well as the cost.<xref ref-type="bibr" rid="article-21939.r36">[36]</xref><xref ref-type="bibr" rid="article-21939.r39">[39]</xref></p>
        <p>The finding of gas on imaging is highly specific for Fournier but is not very sensitive at only 49%.<xref ref-type="bibr" rid="article-21939.r12">[12]</xref><xref ref-type="bibr" rid="article-21939.r54">[54]</xref>&#x000a0;This is because the gas in the deep fascia may not be easily visualized or be spread out too thinly, potentially giving a false negative result.<xref ref-type="bibr" rid="article-21939.r56">[56]</xref></p>
        <p>
<bold>In cases where the diagnosis is clear, and the patient is unstable or septic, surgical treatment should begin immediately and not wait for confirmatory imaging or laboratory diagnostics. In questionable cases, it is far better to perform a surgery that retrospectively might be unnecessary than to delay the procedure and allow a potentially life-threatening infection to progress.</bold>
</p>
      </sec>
      <sec id="article-21939.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Fournier gangrene is a true surgical emergency. The disease process is managed with both surgical interventions&#x000a0;and medical resuscitation as patients will often be septic and in shock.<xref ref-type="bibr" rid="article-21939.r34">[34]</xref>&#x000a0;</p>
        <p>Medical intervention revolves around the initiation of empiric broad-spectrum antibiotics while awaiting culture sensitivities. Antibiotic therapy has historically involved triple therapy in covering gram-positive, gram-negative, and anaerobic organisms associated with Fournier gangrene. These typically include staphylococcus, streptococcus, coliforms, <italic toggle="yes">Pseudomonas, Bacteroides, Clostridium</italic>, and possibly yeast.<xref ref-type="bibr" rid="article-21939.r39">[39]</xref>&#x000a0;The combination of a third-generation cephalosporin, aminoglycoside, penicillin, and metronidazole, has classically been used as triple therapy antibiotic coverage. Antibiotic therapy typically requires a duration of at least two weeks.</p>
        <p><bold>Current recommended antibiotic regimens for Fournier gangrene include</bold>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Carbapenems (imipenem or meropenem 1 g IV every 6-8 hours, ertapenem 1 g IV every 24 hours<xref ref-type="bibr" rid="article-21939.r12">[12]</xref></p>
          </list-item>
        </list>
        <p>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; OR</p>
        <list list-type="bullet">
          <list-item>
            <p>Piperacillin-tazobactam (3.375 g IV every 6 hours or 4.5 g IV every 8 hours)<xref ref-type="bibr" rid="article-21939.r35">[35]</xref></p>
          </list-item>
        </list>
        <p>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; PLUS</p>
        <list list-type="bullet">
          <list-item>
            <p>Clindamycin (600 to 900 mg IV every 8 hours)</p>
          </list-item>
        </list>
        <p>&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; PLUS</p>
        <list list-type="bullet">
          <list-item>
            <p>Vancomycin (15 to 20 mg/kg IV every 8 to 12 hours)<xref ref-type="bibr" rid="article-21939.r51">[51]</xref></p>
          </list-item>
        </list>
        <p>Daptomycin or linezolid can be substituted for vancomycin.<xref ref-type="bibr" rid="article-21939.r12">[12]</xref>&#x000a0;Antifungal agents such as amphotericin B, fluconazole, or similar can be added as needed.<xref ref-type="bibr" rid="article-21939.r35">[35]</xref>&#x000a0;</p>
        <p>Alternate regimens include aminoglycosides or fluoroquinolones plus metronidazole.<xref ref-type="bibr" rid="article-21939.r35">[35]</xref>&#x000a0;</p>
        <p>In patients who have had exposure to fresh or saltwater, doxycycline can be added for coverage of <italic toggle="yes">Aeromonas hydrophilia </italic>and<italic toggle="yes">&#x000a0;Vibrio vulnificus</italic>.<xref ref-type="bibr" rid="article-21939.r35">[35]</xref><xref ref-type="bibr" rid="article-21939.r51">[51]</xref></p>
        <p>In addition to antibiotic therapy, fluid resuscitation is of great importance in patients who may present with hypotension and septic shock.<xref ref-type="bibr" rid="article-21939.r61">[61]</xref><xref ref-type="bibr" rid="article-21939.r62">[62]</xref>&#x000a0;Vasopressors can be an addition to the patient's resuscitation efforts should their hypotension not be responsive to fluids alone.<xref ref-type="bibr" rid="article-21939.r62">[62]</xref> Electrolyte abnormalities should also be appropriately corrected, preferably with a balanced crystalloid such as Lactated Ringer's solution.<xref ref-type="bibr" rid="article-21939.r12">[12]</xref><xref ref-type="bibr" rid="article-21939.r62">[62]</xref><xref ref-type="bibr" rid="article-21939.r63">[63]</xref><xref ref-type="bibr" rid="article-21939.r64">[64]</xref>&#x000a0;Diabetic patients suffering from Fournier gangrene will need correction of any blood glucose abnormalities.<xref ref-type="bibr" rid="article-21939.r55">[55]</xref>&#x000a0;</p>
        <p>
<bold>As critical as these antibiotic and resuscitative measures are, they should not delay emergent, early, and aggressive surgical exploration and debridement, which is the definitive and critical therapy for Fournier gangrene. Any significant delay in initiating the surgery promptly will result in increased patient morbidity and mortality.</bold>
<xref ref-type="bibr" rid="article-21939.r4">[4]</xref>
<xref ref-type="bibr" rid="article-21939.r28">[28]</xref>
<xref ref-type="bibr" rid="article-21939.r65">[65]</xref>
</p>
        <p>Surgical intervention is based on aggressive, radical, wide resection of all necrotic and gangrenous tissue. The surgical team may be comprised of urology, general surgery, plastic surgery, colorectal surgery, and OB-GYN depending on the particular circumstances of the individual case. If there is any doubt about the specialty to take charge of the case, then all surgical specialties involved should be present in the operating room. If the urethra is involved and a suprapubic tube is needed, or if the gangrene is confined to the scrotum and genitalia, then urology would be expected to be the primary surgical service. If the infection starts in the scrotum but extends well into the lower abdomen and perineum and approaches the rectum, or if a diverting colostomy is required, then general or colorectal surgery must be involved. Regardless, these issues should not delay the initiation of surgical treatment of the patient.</p>
        <p>A shorter time from initial hospital presentation to surgical intervention has been associated with improved prognosis; therefore, efforts should be made to minimize this time and avoid delays.<xref ref-type="bibr" rid="article-21939.r4">[4]</xref><xref ref-type="bibr" rid="article-21939.r28">[28]</xref>&#x000a0;Surgical debridement is based on removing all dead, infected, and necrotic tissue. This is determined by the separation of the skin, and subcutaneous tissue with debridement halted when these tissues can no longer be easily separated. The area of necrosis and debridement is often much larger than the skin demarcation alone would suggest. Removal or excision of otherwise healthy skin, particularly in the scrotum, may be necessary for full exposure and prevent premature skin closure before the underlying tissues have adequately healed.</p>
        <p>Other specialties that may be involved with these difficult and complex cases include anesthesiology, critical care, emergency physicians, endocrinology, infectious disease, internal medicine (hospitalists), nephrology, and wound care.</p>
        <p>The testicles have a separate blood supply through the spermatic cord, so they are typically unaffected, even if extensive scrotal involvement is present.<xref ref-type="bibr" rid="article-21939.r50">[50]</xref> In such cases, the testicles can temporarily be placed in a subcutaneous pouch typically made in the upper inner thighs to help preserve their function and surface hydration. Permanent localization of the testicles can be done by a&#x000a0;scrotal advancement flap, but long-term complications are minimized by using a pudendal thigh flap for one or both sides.<xref ref-type="bibr" rid="article-21939.r5">[5]</xref><xref ref-type="bibr" rid="article-21939.r66">[66]</xref><xref ref-type="bibr" rid="article-21939.r67">[67]</xref></p>
        <p>The penile corpora cavernosa and urethra are usually preserved, although the penile skin may become involved.<xref ref-type="bibr" rid="article-21939.r68">[68]</xref></p>
        <p>Surgical debridement often takes place in stages, with most cases of severe Fournier gangrene requiring three separate procedures.<xref ref-type="bibr" rid="article-21939.r55">[55]</xref><xref ref-type="bibr" rid="article-21939.r69">[69]</xref>&#x000a0;A vacuum-assisted closure or wound VAC system dressing is often used following debridement and reconstruction procedures to minimize fluid collections, reduce skin defects, and enhance tissue healing.<xref ref-type="bibr" rid="article-21939.r33">[33]</xref><xref ref-type="bibr" rid="article-21939.r70">[70]</xref><xref ref-type="bibr" rid="article-21939.r71">[71]</xref>&#x000a0;This enhancement is based on exposing the tissue to subatmospheric pressures for prolonged periods, promoting debridement and healing.<xref ref-type="bibr" rid="article-21939.r55">[55]</xref><xref ref-type="bibr" rid="article-21939.r72">[72]</xref></p>
        <p>Following surgical debridement and the formation of granulation tissue, patients will need to undergo reconstructive surgery of the affected area. Skin involvement guides reconstruction effects, which involve one or more of the following: skin flaps or grafts with local tissue, stem cell utilization, and/or split autodermoplasty.&#x000a0;</p>
        <p>Patients with significant perineal involvement will often undergo a colostomy or utilize a fecal management system for feces diversion to aid local healing. Fecal management systems have their basis around bowel management catheters. The system involves the insertion of the catheter into the rectum with a syringe for irrigation&#x000a0;and a collection bag. A diverting colostomy is indicated in patients where the infectious process originated from the anorectal area&#x000a0;and subsequently involved the anal sphincter. Other indications include rectal perforation, large rectal wound, or systemic sepsis.&#x000a0;</p>
        <p>A diverting colostomy is often performed using the Trephine technique. This technique uses a flexible sigmoidoscope to transilluminate&#x000a0;and locate the sigmoid colon. The stoma site is determined intra-operatively. A trephine is performed, and while holding the colon, the sigmoidoscope is withdrawn. The colon is delivered into the wound, and an end colostomy is formed. When compared, fecal management systems have been shown to have a decreased length of hospitalization (24.1 days) compared to patients who have received a colostomy (40.5 days).<xref ref-type="bibr" rid="article-21939.r73">[73]</xref><xref ref-type="bibr" rid="article-21939.r74">[74]</xref><xref ref-type="bibr" rid="article-21939.r75">[75]</xref>&#x000a0;However, using a diverting colostomy tends to indicate a poorer outcome and has not been proven to reduce mortality.<xref ref-type="bibr" rid="article-21939.r76">[76]</xref><xref ref-type="bibr" rid="article-21939.r77">[77]</xref>&#x000a0;Therefore, its use should be considered carefully based on individual patient circumstances, disease severity, the degree of rectal/anal damage, and sphincter involvement.</p>
        <p>The use of hyperbaric oxygen, topical therapy, immunotherapy,&#x000a0; and therapeutic plasma exchange are other treatment modalities that are potentially useful for the treatment of Fournier gangrene; however, medical and especially surgical treatment takes priority. Hyperbaric oxygen therapy is&#x000a0;a supplemental postoperative treatment option that appears helpful.<xref ref-type="bibr" rid="article-21939.r78">[78]</xref><xref ref-type="bibr" rid="article-21939.r79">[79]</xref><xref ref-type="bibr" rid="article-21939.r80">[80]</xref><xref ref-type="bibr" rid="article-21939.r81">[81]</xref><xref ref-type="bibr" rid="article-21939.r82">[82]</xref>&#x000a0;It is typically used after initial surgical debridement, and there is evidence that it improves survival and reduces morbidity.<xref ref-type="bibr" rid="article-21939.r78">[78]</xref><xref ref-type="bibr" rid="article-21939.r79">[79]</xref><xref ref-type="bibr" rid="article-21939.r80">[80]</xref><xref ref-type="bibr" rid="article-21939.r81">[81]</xref><xref ref-type="bibr" rid="article-21939.r82">[82]</xref><xref ref-type="bibr" rid="article-21939.r83">[83]</xref>&#x000a0;</p>
        <p>The premise is that the hyperbaric environment results in the improvement of tissue oxygenation, thereby improving antibiotic delivery and efficacy as well as promoting wound healing.<xref ref-type="bibr" rid="article-21939.r78">[78]</xref>&#x000a0; While there are some reports of an increased mortality rate in Fournier gangrene patients receiving hyperbaric oxygen but this is generally attributed to the use of hyperbaric treatment only in the most severe cases.<xref ref-type="bibr" rid="article-21939.r84">[84]</xref><xref ref-type="bibr" rid="article-21939.r85">[85]</xref>&#x000a0;Hyperbaric therapy should only be used postoperatively and should never be allowed to delay surgical intervention.<xref ref-type="bibr" rid="article-21939.r84">[84]</xref>&#x000a0;</p>
        <p>The application of honey to the affected areas has also been reported to improve wound healing, but no studies have thus far been performed to validate this type of therapy.<xref ref-type="bibr" rid="article-21939.r38">[38]</xref><xref ref-type="bibr" rid="article-21939.r55">[55]</xref><xref ref-type="bibr" rid="article-21939.r86">[86]</xref>&#x000a0;Intravenous immunoglobulins have been proposed to help neutralize streptococcal toxins, but there is insufficient data to indicate their beneficial use in Fournier gangrene.<xref ref-type="bibr" rid="article-21939.r87">[87]</xref><xref ref-type="bibr" rid="article-21939.r88">[88]</xref>&#x000a0;Similarly, therapeutic plasma exchange has been suggested to remove toxins and inflammatory mediators from patients, but there is insufficient evidence to recommend it at the current time.<xref ref-type="bibr" rid="article-21939.r87">[87]</xref></p>
        <p>
<bold>Treatment Summary</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The basis of successful therapy in Fournier gangrene is early recognition and the rapid initiation of surgical debridement.</p>
          </list-item>
          <list-item>
            <p>This should be accompanied by hemodynamic resuscitation and broad-spectrum antibiotics but not delayed unduly.</p>
          </list-item>
          <list-item>
            <p>Imaging and laboratory testing should not delay the start of surgery in obvious or critical cases, as early surgical intervention is the single most significant factor in determining survival.</p>
          </list-item>
          <list-item>
            <p>Extensive, aggressive, and early surgical debridement is the primary mainstay of treatment.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>After surgery, wounds are managed by sterile dressings and vacuum wound pressure systems.</p>
          </list-item>
          <list-item>
            <p>The testicles are usually preserved as their blood supply is typically unaffected. They can be placed in subcutaneous pockets, usually on the upper inner thighs or in pudendal thigh pouches.</p>
          </list-item>
          <list-item>
            <p>If the urethra is involved, a suprapubic tube can be placed.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>If the rectum or anus is involved, a diverting colostomy may be needed or an equivalent fecal management system employed.</p>
          </list-item>
          <list-item>
            <p>The use of suprapubic tubes and colostomies should be minimized as they have not been shown to improve mortality and are associated with increased patient morbidity.</p>
          </list-item>
          <list-item>
            <p>Hyperbaric oxygen seems to help reduce morbidity and mortality.</p>
          </list-item>
          <list-item>
            <p>When fully healed, reconstructive surgery can provide reasonably satisfactory results.<xref ref-type="bibr" rid="article-21939.r50">[50]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21939.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for Fournier gangrene includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute renal colic, urolithiasis</p>
          </list-item>
          <list-item>
            <p>Cellulitis</p>
          </list-item>
          <list-item>
            <p>Chancre</p>
          </list-item>
          <list-item>
            <p>Deep vein thrombosis</p>
          </list-item>
          <list-item>
            <p>Epididymitis</p>
          </list-item>
          <list-item>
            <p>Erysipelas</p>
          </list-item>
          <list-item>
            <p>Gangrenous balanitis,</p>
          </list-item>
          <list-item>
            <p>Gangrenous vulvitis</p>
          </list-item>
          <list-item>
            <p>Gas gangrene (clostridial myonecrosis)</p>
          </list-item>
          <list-item>
            <p>Herpes simplex</p>
          </list-item>
          <list-item>
            <p>inguinal lymphogranulomatosis</p>
          </list-item>
          <list-item>
            <p>Invasive candidiasis</p>
          </list-item>
          <list-item>
            <p>Mucormycosis</p>
          </list-item>
          <list-item>
            <p>Orchitis</p>
          </list-item>
          <list-item>
            <p>Perianal/periurethral abscess</p>
          </list-item>
          <list-item>
            <p>Pyoderma gangrenosum</p>
          </list-item>
          <list-item>
            <p>Pyomyositis</p>
          </list-item>
          <list-item>
            <p>Pyonephrosis</p>
          </list-item>
          <list-item>
            <p>Scrotal abscess</p>
          </list-item>
          <list-item>
            <p>Scrotal edema</p>
          </list-item>
          <list-item>
            <p>Stevens-Johnson syndrome</p>
          </list-item>
          <list-item>
            <p>Syphilis</p>
          </list-item>
          <list-item>
            <p>Testicular torsion</p>
          </list-item>
          <list-item>
            <p>Toxic epidermal necrolysis</p>
          </list-item>
          <list-item>
            <p>Toxic shock syndrome</p>
          </list-item>
          <list-item>
            <p>Vasculitis<xref ref-type="bibr" rid="article-21939.r34">[34]</xref><xref ref-type="bibr" rid="article-21939.r55">[55]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21939.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of Fournier gangrene is multifactorial.</p>
        <p>A study published in 1995 by Laor et al. showed that the development of the Fournier Gangrene Severity Index (FGSI) is useful in determining prognosis in patients suffering from the disease.<xref ref-type="bibr" rid="article-21939.r89">[89]</xref> The index used temperature, heart rate, respiratory rate, serum potassium&#x000a0;and sodium, creatinine, bicarbonate levels, hematocrit, and white blood count. A score of greater than 9 was associated with a mortality of greater than 75 percent, while patients with a score of less than 9 had a 78 percent chance of survival. Other electrolyte abnormalities associated with a worse prognosis include elevated calcium&#x000a0;and low magnesium levels.<xref ref-type="bibr" rid="article-21939.r48">[48]</xref></p>
        <p>A patient's age, as well as the extent of tissue involvement, also determines the prognosis. Patient prognosis declines with advancing age. A larger degree of tissue involvement is similarly associated with a worse prognosis. The Uludag FGSI (UFGSI) scoring system involving both of these factors was developed in 2010 by Yilmazlar et al. Using this newly developed scoring system, a score greater than 9 was associated with a 94% likelihood of death while a score less than 9 correlated with an 81% probability of survival.<xref ref-type="bibr" rid="article-21939.r90">[90]</xref></p>
        <p>The sAPGAR, surgical APGAR score, and the ACCI, age-adjusted Charleston Comorbidity Index, are two general surgical scoring systems that can be used to determine the prognosis of the patient's suffering from Fournier gangrene. ACCI is a prognostic classification system based on assigning points to 19 different comorbidities, with each comorbidity assigned a score of 1, 2, 3, or 6. Higher scores are associated with increased mortality risk. sAPGAR is used to calculate complications in postoperative patients. The score's basis is estimated blood, lowest mean arterial pressure, and lowest heart rate. The lower the sAPGAR score, the higher the risk of complication. While not specific to Fournier gangrene, both sAPGAR&#x000a0;and ACCI are roughly equivalent to the FGSI&#x000a0;and UFGSI in determining patient outcomes.<xref ref-type="bibr" rid="article-21939.r91">[91]</xref>&#x000a0;In studies comparing these scoring systems, the ACCI system demonstrated the highest sensitivity and specificity overall and was among the easiest to use clinically.<xref ref-type="bibr" rid="article-21939.r91">[91]</xref><xref ref-type="bibr" rid="article-21939.r92">[92]</xref></p>
        <p>The time of onset of the disease to surgical treatment is key as patients who present earlier in the course of the disease process and receive prompt, emergent surgical debridement has better outcomes.<xref ref-type="bibr" rid="article-21939.r4">[4]</xref><xref ref-type="bibr" rid="article-21939.r28">[28]</xref> Diabetic patients with a HgA1c greater than 7 have also been found to have a worse prognosis.<xref ref-type="bibr" rid="article-21939.r89">[89]</xref><xref ref-type="bibr" rid="article-21939.r93">[93]</xref></p>
      </sec>
      <sec id="article-21939.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Given the devasting effect that Fournier gangrene has on patients and the high mortality, complications can present both in the short and long term.</p>
        <p>Short-term systemic complications of Fournier gangrene are a result of the inflammatory response mounted by the body against this aggressive infectious process. These systemic complications include acute renal failure, acute respiratory distress syndrome, cardiac arrhythmias, heart failure, multiple organ failure, and bacteremia. This bacteremia can cause acute thromboembolic events such as strokes and arterial occlusion in the lower extremities, which can lead to amputations. Also, patients can develop ileus due to the multiple surgeries they undergo. Wound infections following debridement can also occur; however, as previously discussed, adjunctive treatments such as hyperbaric oxygen are aimed at lowering the rate of wound infections.<xref ref-type="bibr" rid="article-21939.r94">[94]</xref></p>
        <p>Patients who suffer from significant disease involvement of the perineum can often develop fecal incontinence due to the involvement of the anal sphincter, which requires debridement. These patients will require a colostomy to decrease fecal contamination of the wound. The formation of a colostomy itself comes with multiple associated complications. These complications include the evisceration of the stoma and stomal infection. As the penis is often involved, urinary tract infections are common complications of the disease. Urinary retention results from periurethral swelling, which prevents the patient from voiding; treatment includes urinary catheterization and cystostomy in specific patient groups.<xref ref-type="bibr" rid="article-21939.r55">[55]</xref></p>
        <p>Psychological complications are prevalent in patients who suffer from Fournier gangrene. Due to the devastating effect the disease has on the genitals; many patients have long-term pain as a result. This condition leads to a decreased quality of life, which can cause depression. The disfiguring scars associated with the recovery process also contribute to patients&#x02019; psychological problems. Patients will often suffer from sexual dysfunction from impaired penile function, penile deviation, and penile torsion. Loss of penile skin sensitivity and pain associated with erections are two other factors that lead to sexual dysfunction.<xref ref-type="bibr" rid="article-21939.r7">[7]</xref><xref ref-type="bibr" rid="article-21939.r95">[95]</xref></p>
      </sec>
      <sec id="article-21939.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Fournier gangrene is a rare but deadly infection of the genital and perineum. Symptoms of this infectious process include swelling to the genitals and perineal area associated with significant pain. Systemic symptoms are not uncommon. While there is no specific way to prevent Fournier gangrene, certain actions can be taken to minimize the chances of suffering the disease. Diabetic patients should carefully and thoroughly assess the groin area for any signs of redness, swelling, or pain. Also, appropriate management of diabetes with optimal medication compliance is beneficial.&#x000a0;Diabetic patients who suffer from Fournier gangrene have a better prognosis if the HgA1c is below 7. Maintaining appropriate hygiene&#x000a0;and skincare can also prevent Fournier gangrene, as skin breakdown can be the first step in developing the disease.<xref ref-type="bibr" rid="article-21939.r93">[93]</xref></p>
      </sec>
      <sec id="article-21939.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Fournier gangrene is a rapid, life-threatening infection of the genitals&#x000a0;and perineum with a very high mortality rate even with optimal modern medical treatment.</p>
          </list-item>
          <list-item>
            <p>Special care and attention should be given to patients with unexplained groin or scrotal pain, cellulitis, or localized infection, as a misdiagnosis can prove fatal.</p>
          </list-item>
          <list-item>
            <p>Particular attention is necessary for patients who have diabetes, have a history of hypertension, alcohol abuse, spinal cord injury with paraplegia or quadriplegia, morbid obesity, or are immunocompromised as these factors predispose patients to the development of Fournier gangrene or unduly delay the diagnosis.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>On physical examination, the patient may have pain out of proportion to physical findings as there may not be any significant cutaneous manifestations of the disease. Be very suspicious in such situations.</p>
          </list-item>
          <list-item>
            <p>Multiple medical and surgical specialties may need to be involved in these complex cases, including colorectal surgery, critical care, emergency medicine, endocrinology, general surgery, infectious disease, internal medicine, nephrology, OB-GYN, plastic surgery, wound care, and urology.</p>
          </list-item>
          <list-item>
            <p>Medical treatment revolves around medical resuscitation with intravenous fluids&#x000a0;and antibiotics, but priority must be given to emergent surgical exploration and aggressive debridement.</p>
          </list-item>
          <list-item>
            <p>Medical resuscitation measures, laboratory studies, and diagnostic imaging should not be permitted to delay surgical exploration in obvious or clearcut cases.</p>
          </list-item>
          <list-item>
            <p>Rapid surgical treatment is the single most important factor in overall patient survival in this disease.</p>
          </list-item>
          <list-item>
            <p>Using suprapubic tubes and diverting colostomies should be minimized as much as possible as they do not appear to improve mortality and may increase morbidity.</p>
          </list-item>
          <list-item>
            <p>The testicles are usually preserved as their blood supply derives from the spermatic cord. They may be best placed by relocating them in pudendal thigh pouches.</p>
          </list-item>
          <list-item>
            <p>Despite the devastating complications, many patients are ultimately pleased with their quality of life.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21939.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The treatment and management of Fournier gangrene require an interprofessional team. Patients will often present to the emergency department or their primary care physician. Following diagnosis and admission to the hospital, Fournier gangrene management is best by a team of health care professionals, including an intensivist, urologist, pharmacist, infectious disease expert, and nursing staff. In the emergency department, prompt identification of the disease is of great importance. The faster a patient with Fournier gangrene gets evaluated and their workup initiated, the quicker they are accurately diagnosed and treated. Following an appropriate diagnosis, the patient will require admission and urological consultation for prompt surgical debridement. These patients will often require admission to an intensive care unit where their vitals will be continually monitored by nursing staff who will communicate any concerns regarding patient deterioration to the intensivist.</p>
        <p>Pharmacy and infectious disease play crucial roles in determining the appropriate antibiotics, which should be given to the patient once culture sensitivities result. If the wound is left open, a wound care nurse should be involved with the dressing changes. A stoma nurse should assess the appliance and ensure that the skin around the stoma is protected. These patients require vigilent monitoring, and any member of the interprofessional team who notes a change in status, including relapse, therapeutic failure, or drug adverse events or interactions, must document their findings and alert appropriate team members immediately so interventions can commence. This global and systemic interprofessional approach to treating patients suffering from Fournier gangrene is crucial in lowering the associated mortality.<xref ref-type="bibr" rid="article-21939.r33">[33]</xref>&#x000a0;[Level 5]</p>
        <p>Fournier gangrene is a potentially fatal disease with a mortality ranging from 20% to 30%.<xref ref-type="bibr" rid="article-21939.r14">[14]</xref>&#x000a0;Mortality is dependent on age, time to surgical intervention, and predisposing factors such as diabetes mellitus, hypertension, and immunocompromise. If diagnosed&#x000a0;and managed appropriately, most survivors of Fournier gangrene are satisfied with their quality of life and cosmetic results despite complications such as chronic pain, sexual dysfunction, and stool incontinence.<xref ref-type="bibr" rid="article-21939.r96">[96]</xref></p>
      </sec>
      <sec id="article-21939.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21939&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21939">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/fournier-gangrene/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21939">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21939/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21939">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-21939.s17">
        <fig id="article-21939.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Fournier gangrene Contributed by Sunil Munakomi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ap4" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-21939.s18">
        <title>References</title>
        <ref id="article-21939.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carroll</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Cattolica</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Turzan</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>McAninch</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing soft-tissue infections of the perineum and genitalia. Etiology and early reconstruction.</article-title>
            <source>West J Med</source>
            <year>1986</year>
            <month>Feb</month>
            <volume>144</volume>
            <issue>2</issue>
            <fpage>174</fpage>
            <page-range>174-8</page-range>
            <pub-id pub-id-type="pmid">3953086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Short</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Fournier gangrene: an historical reappraisal.</article-title>
            <source>Intern Med J</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>48</volume>
            <issue>9</issue>
            <fpage>1157</fpage>
            <page-range>1157-1160</page-range>
            <pub-id pub-id-type="pmid">30182399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taken</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Oncu</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Ergun</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eryilmaz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Demir</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Demir</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gunes</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene: Causes, presentation and survival of sixty-five patients.</article-title>
            <source>Pak J Med Sci</source>
            <year>2016</year>
            <season>May-Jun</season>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>746</fpage>
            <page-range>746-50</page-range>
            <pub-id pub-id-type="pmid">27375726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Pasupathy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khin</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>CO</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>85</volume>
            <issue>8</issue>
            <fpage>1454</fpage>
            <page-range>1454-60</page-range>
            <pub-id pub-id-type="pmid">12925624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joury</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mahendra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alshehri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Downing</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Extensive necrotizing fasciitis from Fournier's gangrene.</article-title>
            <source>Urol Case Rep</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>26</volume>
            <fpage>100943</fpage>
            <pub-id pub-id-type="pmid">31236328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mishra</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing Soft Tissue Infections: Surgeon's Prospective.</article-title>
            <source>Int J Inflam</source>
            <year>2013</year>
            <volume>2013</volume>
            <fpage>609628</fpage>
            <pub-id pub-id-type="pmid">24455410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thwaini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cherian</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Barua</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shergill</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mammen</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene and its emergency management.</article-title>
            <source>Postgrad Med J</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>82</volume>
            <issue>970</issue>
            <fpage>516</fpage>
            <page-range>516-9</page-range>
            <pub-id pub-id-type="pmid">16891442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Voelzke</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Hagedorn</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Presentation and Diagnosis of Fournier Gangrene.</article-title>
            <source>Urology</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>114</volume>
            <fpage>8</fpage>
            <page-range>8-13</page-range>
            <pub-id pub-id-type="pmid">29146218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellapianta</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ljungquist</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tobin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Uhl</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing fasciitis.</article-title>
            <source>J Am Acad Orthop Surg</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>174</fpage>
            <page-range>174-82</page-range>
            <pub-id pub-id-type="pmid">19264710</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wr&#x000f3;blewska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kuzaka</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Borkowski</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kuzaka</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kawecki</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Radziszewski</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene--current concepts.</article-title>
            <source>Pol J Microbiol</source>
            <year>2014</year>
            <volume>63</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-73</page-range>
            <pub-id pub-id-type="pmid">25546936</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bjurlin</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>O'Grady</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Divakaruni</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Drago</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Blumetti</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hollowell</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier's gangrene.</article-title>
            <source>Urology</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>81</volume>
            <issue>4</issue>
            <fpage>752</fpage>
            <page-range>752-8</page-range>
            <pub-id pub-id-type="pmid">23434087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Auerbach</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bornstein</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ramzy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cabrera</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Montrief</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Fournier Gangrene in the Emergency Department: Diagnostic Dilemmas, Treatments and Current Perspectives.</article-title>
            <source>Open Access Emerg Med</source>
            <year>2020</year>
            <volume>12</volume>
            <fpage>353</fpage>
            <page-range>353-364</page-range>
            <pub-id pub-id-type="pmid">33204184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heijkoop</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Spernat</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene: not as lethal as previously thought? A case series.</article-title>
            <source>ANZ J Surg</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>89</volume>
            <issue>4</issue>
            <fpage>350</fpage>
            <page-range>350-352</page-range>
            <pub-id pub-id-type="pmid">30173412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sparenborg</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Brems</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Venkatesan</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene: a modern analysis of predictors of outcomes.</article-title>
            <source>Transl Androl Urol</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>374</fpage>
            <page-range>374-378</page-range>
            <pub-id pub-id-type="pmid">31555561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuzaka</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wr&#x000f3;blewska</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Borkowski</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kawecki</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kuzaka</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>M&#x00142;ynarczyk</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Radziszewski</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene: Clinical Presentation of 13 Cases.</article-title>
            <source>Med Sci Monit</source>
            <year>2018</year>
            <month>Jan</month>
            <day>28</day>
            <volume>24</volume>
            <fpage>548</fpage>
            <page-range>548-555</page-range>
            <pub-id pub-id-type="pmid">29374769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Qushayri</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Khalaf</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Dahy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mahmoud</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Benmelouka</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Ghozy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mahmoud</surname>
                <given-names>MU</given-names>
              </name>
              <name>
                <surname>Bin-Jumah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alkahtani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Abdel-Daim</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene mortality: A 17-year systematic review and meta-analysis.</article-title>
            <source>Int J Infect Dis</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>92</volume>
            <fpage>218</fpage>
            <page-range>218-225</page-range>
            <pub-id pub-id-type="pmid">31962181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gadler</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Huey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Recognizing Fournier's Gangrene in the Emergency Department.</article-title>
            <source>Adv Emerg Nurs J</source>
            <year>2019</year>
            <season>Jan/Mar</season>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>33</fpage>
            <page-range>33-38</page-range>
            <pub-id pub-id-type="pmid">30702531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sorensen</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Krieger</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene: Epidemiology and Outcomes in the General US Population.</article-title>
            <source>Urol Int</source>
            <year>2016</year>
            <volume>97</volume>
            <issue>3</issue>
            <fpage>249</fpage>
            <page-range>249-259</page-range>
            <pub-id pub-id-type="pmid">27172977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sorensen</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Krieger</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Rivara</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Broghammer</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Wessells</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene: population based epidemiology and outcomes.</article-title>
            <source>J Urol</source>
            <year>2009</year>
            <month>May</month>
            <volume>181</volume>
            <issue>5</issue>
            <fpage>2120</fpage>
            <page-range>2120-6</page-range>
            <pub-id pub-id-type="pmid">19286224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elem</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ranjan</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Impact of immunodeficiency virus (HIV) on Fournier's gangrene: observations in Zambia.</article-title>
            <source>Ann R Coll Surg Engl</source>
            <year>1995</year>
            <month>Jul</month>
            <volume>77</volume>
            <issue>4</issue>
            <fpage>283</fpage>
            <page-range>283-6</page-range>
            <pub-id pub-id-type="pmid">7574321</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moussa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abou Chakra</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Isolated Penile Fournier's gangrene: A case report and literature review.</article-title>
            <source>Int J Surg Case Rep</source>
            <year>2019</year>
            <volume>62</volume>
            <fpage>65</fpage>
            <page-range>65-68</page-range>
            <pub-id pub-id-type="pmid">31450216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mouraviev</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Pautler</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Hayman</surname>
                <given-names>WP</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene following penile self-injection with cocaine.</article-title>
            <source>Scand J Urol Nephrol</source>
            <year>2002</year>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>317</fpage>
            <page-range>317-8</page-range>
            <pub-id pub-id-type="pmid">12201928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bloomgarden</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Einhorn</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Grunberger</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Handelsman</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene and sodium-glucose cotransporter 2 inhibitors: Is there a causal association?</article-title>
            <source>J Diabetes</source>
            <year>2019</year>
            <month>May</month>
            <volume>11</volume>
            <issue>5</issue>
            <fpage>340</fpage>
            <page-range>340-341</page-range>
            <pub-id pub-id-type="pmid">30600643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perkins</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Bieniek</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sumfest</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Solitary Candida albicans Infection Causing Fournier Gangrene and Review of Fungal Etiologies.</article-title>
            <source>Rev Urol</source>
            <year>2014</year>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>95</fpage>
            <page-range>95-8</page-range>
            <pub-id pub-id-type="pmid">25009452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Serrano Olave</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bueno Moral</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez Ba&#x000f1;&#x000f3;n</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez Mesa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jim&#x000e9;nez L&#x000f3;pez</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene under Sodium-Glucose Cotransporter-2 Inhibitors Therapy in Gynecological Patients.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2022</year>
            <month>May</month>
            <day>21</day>
            <volume>19</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">35627798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rudd</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Agesa</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Shackelford</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Tsoi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kievlan</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Colombara</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Ikuta</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Kissoon</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Finfer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fleischmann-Struzek</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Machado</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Reinhart</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Rowan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Seymour</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Marinho</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hay</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Lozano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>CJL</given-names>
              </name>
              <name>
                <surname>Naghavi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.</article-title>
            <source>Lancet</source>
            <year>2020</year>
            <month>Jan</month>
            <day>18</day>
            <volume>395</volume>
            <issue>10219</issue>
            <fpage>200</fpage>
            <page-range>200-211</page-range>
            <pub-id pub-id-type="pmid">31954465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Radcliffe</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Mortality associated with Fournier's gangrene remains unchanged over 25&#x000a0;years.</article-title>
            <source>BJU Int</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>125</volume>
            <issue>4</issue>
            <fpage>610</fpage>
            <page-range>610-616</page-range>
            <pub-id pub-id-type="pmid">31975540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peetermans</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Prost</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Eckmann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Norrby-Teglund</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Skrede</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De Waele</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing skin and soft-tissue infections in the intensive care unit.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-17</page-range>
            <pub-id pub-id-type="pmid">31284035</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sugihara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yasunaga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Horiguchi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fujimura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ohe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Matsuda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fushimi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Homma</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Impact of surgical intervention timing on the case fatality rate for Fournier's gangrene: an analysis of 379 cases.</article-title>
            <source>BJU Int</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>110</volume>
            <issue>11 Pt C</issue>
            <fpage>E1096</fpage>
            <page-range>E1096-100</page-range>
            <pub-id pub-id-type="pmid">22726768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Bunker</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Dinneen</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene.</article-title>
            <source>Br J Urol</source>
            <year>1998</year>
            <month>Mar</month>
            <volume>81</volume>
            <issue>3</issue>
            <fpage>347</fpage>
            <page-range>347-55</page-range>
            <pub-id pub-id-type="pmid">9523650</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wetterauer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ebbing</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Halla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kuehl</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Erb</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Egli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schaefer</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Seifert</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>A contemporary case series of Fournier's gangrene at a Swiss tertiary care center-can scoring systems accurately predict mortality and morbidity?</article-title>
            <source>World J Emerg Surg</source>
            <year>2018</year>
            <volume>13</volume>
            <fpage>25</fpage>
            <pub-id pub-id-type="pmid">29977327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thayer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mailey</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Two-stage Neoscrotum Reconstruction Using Porcine Bladder Extracellular Matrix after Fournier's Gangrene.</article-title>
            <source>Plast Reconstr Surg Glob Open</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>e3034</fpage>
            <pub-id pub-id-type="pmid">32983789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ioannidis</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Kitsikosta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tatsis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Skandalos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cheva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gkioti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Varnalidis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Symeonidis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Savvala</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Parpoudi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Paraskevas</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Pramateftakis</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Kotidis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mantzoros</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tsalis</surname>
                <given-names>KG</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene: Lessons Learned from Multimodal and Multidisciplinary Management of Perineal Necrotizing Fasciitis.</article-title>
            <source>Front Surg</source>
            <year>2017</year>
            <volume>4</volume>
            <fpage>36</fpage>
            <pub-id pub-id-type="pmid">28740847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chernyadyev</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Ufimtseva</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Vishnevskaya</surname>
                <given-names>IF</given-names>
              </name>
              <name>
                <surname>Bochkarev</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Ushakov</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Beresneva</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Galimzyanov</surname>
                <given-names>FV</given-names>
              </name>
              <name>
                <surname>Khodakov</surname>
                <given-names>VV</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene: Literature Review and Clinical Cases.</article-title>
            <source>Urol Int</source>
            <year>2018</year>
            <volume>101</volume>
            <issue>1</issue>
            <fpage>91</fpage>
            <page-range>91-97</page-range>
            <pub-id pub-id-type="pmid">29949811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montrief</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Koyfman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Auerbach</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Fournier Gangrene: A Review for Emergency Clinicians.</article-title>
            <source>J Emerg Med</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>488</fpage>
            <page-range>488-500</page-range>
            <pub-id pub-id-type="pmid">31472943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ballard</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Mazaheri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Raptis</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Lubner</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Menias</surname>
                <given-names>CO</given-names>
              </name>
              <name>
                <surname>Pickhardt</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Mellnick</surname>
                <given-names>VM</given-names>
              </name>
            </person-group>
            <article-title>Fournier Gangrene in Men and Women: Appearance on CT, Ultrasound, and MRI and What the Surgeon Wants to Know.</article-title>
            <source>Can Assoc Radiol J</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>71</volume>
            <issue>1</issue>
            <fpage>30</fpage>
            <page-range>30-39</page-range>
            <pub-id pub-id-type="pmid">32063012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Goh</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Ang</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Early diagnosis of necrotizing fasciitis.</article-title>
            <source>Br J Surg</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>101</volume>
            <issue>1</issue>
            <fpage>e119</fpage>
            <page-range>e119-25</page-range>
            <pub-id pub-id-type="pmid">24338771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Aydin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Dasgupta</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene. A clinical review.</article-title>
            <source>Arch Ital Urol Androl</source>
            <year>2016</year>
            <month>Oct</month>
            <day>05</day>
            <volume>88</volume>
            <issue>3</issue>
            <fpage>157</fpage>
            <page-range>157-164</page-range>
            <pub-id pub-id-type="pmid">27711086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hakkarainen</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Kopari</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Pham</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>HL</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes.</article-title>
            <source>Curr Probl Surg</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>51</volume>
            <issue>8</issue>
            <fpage>344</fpage>
            <page-range>344-62</page-range>
            <pub-id pub-id-type="pmid">25069713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castleberg</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jenson</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dinh</surname>
                <given-names>VA</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of necrotizing faciitis with bedside ultrasound: the STAFF Exam.</article-title>
            <source>West J Emerg Med</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <page-range>111-3</page-range>
            <pub-id pub-id-type="pmid">24578776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singam</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Ruffey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chou</surname>
                <given-names>TG</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene: A Case of Neglected Symptoms with Devastating Physical Loss.</article-title>
            <source>Malays J Med Sci</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>81</fpage>
            <page-range>81-4</page-range>
            <pub-id pub-id-type="pmid">23610554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saijo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kuramoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yoshinari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tagami</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Extremely extended Fournier's gangrene.</article-title>
            <source>Dermatologica</source>
            <year>1990</year>
            <volume>181</volume>
            <issue>3</issue>
            <fpage>228</fpage>
            <page-range>228-32</page-range>
            <pub-id pub-id-type="pmid">2269383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferreira</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Reis</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Amarante</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>&#x000c1;C</given-names>
              </name>
              <name>
                <surname>Pinho</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>da Silva</surname>
                <given-names>PN</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene: a review of 43 reconstructive cases.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>119</volume>
            <issue>1</issue>
            <fpage>175</fpage>
            <page-range>175-184</page-range>
            <pub-id pub-id-type="pmid">17255671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Talwar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Puri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene of the Penis: A Rare Entity.</article-title>
            <source>J Cutan Aesthet Surg</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-4</page-range>
            <pub-id pub-id-type="pmid">20606995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferretti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saji</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene: A Review and Outcome Comparison from 2009 to 2016.</article-title>
            <source>Adv Wound Care (New Rochelle)</source>
            <year>2017</year>
            <month>Sep</month>
            <day>01</day>
            <volume>6</volume>
            <issue>9</issue>
            <fpage>289</fpage>
            <page-range>289-295</page-range>
            <pub-id pub-id-type="pmid">28894636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nigam</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Halim</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Chhabra</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene in a female with spinal cord injury: a case report.</article-title>
            <source>Spinal Cord</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>268</fpage>
            <page-range>268-9</page-range>
            <pub-id pub-id-type="pmid">19786974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fan</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Remick</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <article-title>Diagnosing sepsis - The role of laboratory medicine.</article-title>
            <source>Clin Chim Acta</source>
            <year>2016</year>
            <month>Sep</month>
            <day>01</day>
            <volume>460</volume>
            <fpage>203</fpage>
            <page-range>203-10</page-range>
            <pub-id pub-id-type="pmid">27387712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sayana</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kala</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rai</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of the Utility of the Fournier's Gangrene Severity Index in the Management of Fournier's Gangrene in North India: A Multicentre Retrospective Study.</article-title>
            <source>J Cutan Aesthet Surg</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>273</fpage>
            <page-range>273-6</page-range>
            <pub-id pub-id-type="pmid">23378710</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eke</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene: a review of 1726 cases.</article-title>
            <source>Br J Surg</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>87</volume>
            <issue>6</issue>
            <fpage>718</fpage>
            <page-range>718-28</page-range>
            <pub-id pub-id-type="pmid">10848848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chennamsetty</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Khourdaji</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Burks</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Killinger</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Contemporary diagnosis and management of Fournier's gangrene.</article-title>
            <source>Ther Adv Urol</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>203</fpage>
            <page-range>203-15</page-range>
            <pub-id pub-id-type="pmid">26445600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Serafino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gullotto</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gregorini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nocentini</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>A clinical case of Fournier's gangrene: imaging ultrasound.</article-title>
            <source>J Ultrasound</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>303</fpage>
            <page-range>303-6</page-range>
            <pub-id pub-id-type="pmid">25368689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yen</surname>
                <given-names>ZS</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Ultrasonographic screening of clinically-suspected necrotizing fasciitis.</article-title>
            <source>Acad Emerg Med</source>
            <year>2002</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>12</issue>
            <fpage>1448</fpage>
            <page-range>1448-51</page-range>
            <pub-id pub-id-type="pmid">12460854</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levenson</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Novelline</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Fournier gangrene: role of imaging.</article-title>
            <source>Radiographics</source>
            <year>2008</year>
            <season>Mar-Apr</season>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>519</fpage>
            <page-range>519-28</page-range>
            <pub-id pub-id-type="pmid">18349455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fernando</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Rochwerg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kyeremanteng</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Seely</surname>
                <given-names>AJE</given-names>
              </name>
              <name>
                <surname>Inaba</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing Soft Tissue Infection: Diagnostic Accuracy of Physical Examination, Imaging, and LRINEC Score: A Systematic Review and Meta-Analysis.</article-title>
            <source>Ann Surg</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>269</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <page-range>58-65</page-range>
            <pub-id pub-id-type="pmid">29672405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mallikarjuna</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Vijayakumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Shivswamy</surname>
                <given-names>BS</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene: Current Practices.</article-title>
            <source>ISRN Surg</source>
            <year>2012</year>
            <volume>2012</volume>
            <fpage>942437</fpage>
            <pub-id pub-id-type="pmid">23251819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wysoki</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Santora</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing fasciitis: CT characteristics.</article-title>
            <source>Radiology</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>203</volume>
            <issue>3</issue>
            <fpage>859</fpage>
            <page-range>859-63</page-range>
            <pub-id pub-id-type="pmid">9169717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajan</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Scharer</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Radiology of Fournier's gangrene.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>170</volume>
            <issue>1</issue>
            <fpage>163</fpage>
            <page-range>163-8</page-range>
            <pub-id pub-id-type="pmid">9423625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piedra</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ru&#x000ed;z</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Arnaiz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lastra</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Rasines</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene: a radiologic emergency.</article-title>
            <source>Abdom Imaging</source>
            <year>2006</year>
            <season>Jul-Aug</season>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>500</fpage>
            <page-range>500-2</page-range>
            <pub-id pub-id-type="pmid">16947074</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elmi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Kusbeci</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Osoble Osman</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>A case report of Fournier's gangrene: Imaging ultrasound and computed tomography (CT) scan.</article-title>
            <source>Radiol Case Rep</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>959</fpage>
            <page-range>959-962</page-range>
            <pub-id pub-id-type="pmid">35106103</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nepal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ojili</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tirumani</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Nagar</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Gas Where It Shouldn't Be! Imaging Spectrum of Emphysematous Infections in the Abdomen and Pelvis.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>216</volume>
            <issue>3</issue>
            <fpage>812</fpage>
            <page-range>812-823</page-range>
            <pub-id pub-id-type="pmid">33439049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morgan</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of necrotising fasciitis: a multiparametric approach.</article-title>
            <source>J Hosp Infect</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>75</volume>
            <issue>4</issue>
            <fpage>249</fpage>
            <page-range>249-57</page-range>
            <pub-id pub-id-type="pmid">20542593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Evans</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rhodes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alhazzani</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Antonelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Coopersmith</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Machado</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Mcintyre</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ostermann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Prescott</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Schorr</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wiersinga</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Alshamsi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Arabi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Azevedo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Beale</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Beilman</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Belley-Cote</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Burry</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cecconi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Centofanti</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Coz Yataco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Waele</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dellinger</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Doi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Estenssoro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ferrer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gomersall</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hodgson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hylander M&#x000f8;ller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iwashyna</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jacob</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kleinpell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Klompas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kwizera</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lobo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Masur</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>McGloughlin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nunnally</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oczkowski</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Osborn</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Papathanassoglou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Perner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Puskarich</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schweickert</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Seckel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sevransky</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sprung</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Welte</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.</article-title>
            <source>Crit Care Med</source>
            <year>2021</year>
            <month>Nov</month>
            <day>01</day>
            <volume>49</volume>
            <issue>11</issue>
            <fpage>e1063</fpage>
            <page-range>e1063-e1143</page-range>
            <pub-id pub-id-type="pmid">34605781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toporek</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Semler</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Self</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Bernard</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Siew</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Stollings</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Wanderer</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>JD</given-names>
              </name>
              <collab>SMART Investigators and the Pragmatic Critical Care Research Group</collab>
            </person-group>
            <article-title>Balanced Crystalloids versus Saline in Critically Ill Adults with Hyperkalemia or Acute Kidney Injury: Secondary Analysis of a Clinical Trial.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2021</year>
            <month>May</month>
            <day>15</day>
            <volume>203</volume>
            <issue>10</issue>
            <fpage>1322</fpage>
            <page-range>1322-1325</page-range>
            <pub-id pub-id-type="pmid">33503391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benjelloun</surname>
                <given-names>el B</given-names>
              </name>
              <name>
                <surname>Souiki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yakla</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ousadden</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mazaz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Louchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kanjaa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Taleb</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene: our experience with 50 patients and analysis of factors affecting mortality.</article-title>
            <source>World J Emerg Surg</source>
            <year>2013</year>
            <month>Apr</month>
            <day>01</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <pub-id pub-id-type="pmid">23547796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kabay</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yucel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yaylak</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Algin</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Hacioglu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kabay</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Muslumanoglu</surname>
                <given-names>AY</given-names>
              </name>
            </person-group>
            <article-title>The clinical features of Fournier's gangrene and the predictivity of the Fournier's Gangrene Severity Index on the outcomes.</article-title>
            <source>Int Urol Nephrol</source>
            <year>2008</year>
            <volume>40</volume>
            <issue>4</issue>
            <fpage>997</fpage>
            <page-range>997-1004</page-range>
            <pub-id pub-id-type="pmid">18563618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kincius</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Telksnys</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Trumbeckas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jievaltas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Milonas</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of LRINEC Scale Feasibility for Predicting Outcomes of Fournier Gangrene.</article-title>
            <source>Surg Infect (Larchmt)</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>448</fpage>
            <page-range>448-53</page-range>
            <pub-id pub-id-type="pmid">27023717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Sabbagh</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Coverage of the scrotum after Fournier's gangrene.</article-title>
            <source>GMS Interdiscip Plast Reconstr Surg DGPW</source>
            <year>2018</year>
            <volume>7</volume>
            <fpage>Doc01</fpage>
            <pub-id pub-id-type="pmid">29423355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Campos</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Martos</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Guti&#x000e9;rrez del Pozo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Carretero</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Synchronous caverno-spongious thrombosis and Fournier's gangrene.</article-title>
            <source>Arch Esp Urol</source>
            <year>1990</year>
            <month>May</month>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>423</fpage>
            <page-range>423-6</page-range>
            <pub-id pub-id-type="pmid">2383054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chawla</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Gallop</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mydlo</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene: an analysis of repeated surgical debridement.</article-title>
            <source>Eur Urol</source>
            <year>2003</year>
            <month>May</month>
            <volume>43</volume>
            <issue>5</issue>
            <fpage>572</fpage>
            <page-range>572-5</page-range>
            <pub-id pub-id-type="pmid">12706005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hong</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Yi</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors and treatment outcomes for patients with Fournier's gangrene: a retrospective study.</article-title>
            <source>Int Wound J</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>1352</fpage>
            <page-range>1352-1358</page-range>
            <pub-id pub-id-type="pmid">28944569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ozkan</surname>
                <given-names>OF</given-names>
              </name>
              <name>
                <surname>Koksal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Altinli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Celik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Uzun</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>C&#x00131;kman</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Akbas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ergun</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kiraz</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Karaayvaz</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene current approaches.</article-title>
            <source>Int Wound J</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>713</fpage>
            <page-range>713-6</page-range>
            <pub-id pub-id-type="pmid">25145578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinfeld</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Kelley</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yuksel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tiwari</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Choo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hollier</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Circumferential negative-pressure dressing (VAC) to bolster skin grafts in the reconstruction of the penile shaft and scrotum.</article-title>
            <source>Ann Plast Surg</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>178</fpage>
            <page-range>178-83</page-range>
            <pub-id pub-id-type="pmid">15655470</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oguz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>G&#x000fc;m&#x000fc;&#x0015f;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Turkoglu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bozda&#x0011f;</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>&#x000dc;lger</surname>
                <given-names>BV</given-names>
              </name>
              <name>
                <surname>Aga&#x000e7;ayak</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>B&#x000f6;y&#x000fc;k</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene: A Summary of 10 Years of Clinical Experience.</article-title>
            <source>Int Surg</source>
            <year>2015</year>
            <month>May</month>
            <volume>100</volume>
            <issue>5</issue>
            <fpage>934</fpage>
            <page-range>934-41</page-range>
            <pub-id pub-id-type="pmid">25859652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lordan</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Rawal</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Simson</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Safe and simple trephine loop colostomy.</article-title>
            <source>Ann R Coll Surg Engl</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>89</volume>
            <issue>6</issue>
            <fpage>634</fpage>
            <page-range>634-5</page-range>
            <pub-id pub-id-type="pmid">18213741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eray</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Alabaz</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Akcam</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Ulku</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parsak</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Sakman</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Seydaoglu</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Diverting Colostomy and Bowel Management Catheter Applications in Fournier Gangrene Cases Requiring Fecal Diversion.</article-title>
            <source>Indian J Surg</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>77</volume>
            <issue>Suppl 2</issue>
            <fpage>438</fpage>
            <page-range>438-41</page-range>
            <pub-id pub-id-type="pmid">26730041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarofim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Di Re</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Descallar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Toh</surname>
                <given-names>JWT</given-names>
              </name>
            </person-group>
            <article-title>Relationship between diversional stoma and mortality rate in Fournier's gangrene: a systematic review and meta-analysis.</article-title>
            <source>Langenbecks Arch Surg</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>406</volume>
            <issue>8</issue>
            <fpage>2581</fpage>
            <page-range>2581-2590</page-range>
            <pub-id pub-id-type="pmid">33864128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosen</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Cologne</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Ault</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Strumwasser</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Long-term follow-up of Fournier's Gangrene in a tertiary care center.</article-title>
            <source>J Surg Res</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>206</volume>
            <issue>1</issue>
            <fpage>175</fpage>
            <page-range>175-181</page-range>
            <pub-id pub-id-type="pmid">27916359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosa</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Guerreiro</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric Oxygen Therapy for the Treatment of Fournier's Gangrene: A Review of 34 Cases.</article-title>
            <source>Acta Med Port</source>
            <year>2015</year>
            <season>Sep-Oct</season>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>619</fpage>
            <page-range>619-23</page-range>
            <pub-id pub-id-type="pmid">26667866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feres</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Feitosa</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Ribeiro da Rocha</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Miranda</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Dos Santos</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>F&#x000e9;res</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>de Camargo</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Parra</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric oxygen therapy decreases mortality due to Fournier's gangrene: a retrospective comparative study.</article-title>
            <source>Med Gas Res</source>
            <year>2021</year>
            <season>Jan-Mar</season>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>18</fpage>
            <page-range>18-23</page-range>
            <pub-id pub-id-type="pmid">33642333</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Creta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Longo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Arcaniolo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Giannella</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cicalese</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Nunzio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Grimaldi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cicalese</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>De Sio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Autorino</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fedelini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marmo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Capece</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>La Rocca</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tubaro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Imbimbo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mirone</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Fusco</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric oxygen therapy reduces mortality in patients with Fournier's Gangrene. Results from a multi-institutional observational study.</article-title>
            <source>Minerva Urol Nefrol</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>72</volume>
            <issue>2</issue>
            <fpage>223</fpage>
            <page-range>223-228</page-range>
            <pub-id pub-id-type="pmid">32083420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hedetoft</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Hyldegaard</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Adjunctive hyperbaric oxygen treatment for necrotising soft-tissue infections: A systematic review and meta-analysis.</article-title>
            <source>Diving Hyperb Med</source>
            <year>2021</year>
            <month>Mar</month>
            <day>31</day>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <page-range>34-43</page-range>
            <pub-id pub-id-type="pmid">33761539</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mindrup</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Kealey</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Fallon</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric oxygen for the treatment of fournier's gangrene.</article-title>
            <source>J Urol</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>173</volume>
            <issue>6</issue>
            <fpage>1975</fpage>
            <page-range>1975-7</page-range>
            <pub-id pub-id-type="pmid">15879795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raizandha</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Hidayatullah</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kloping</surname>
                <given-names>YP</given-names>
              </name>
              <name>
                <surname>Rahman</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Djatisoesanto</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Rizaldi</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The role of hyperbaric oxygen therapy in Fournier's Gangrene: A systematic review and meta-analysis of observational studies.</article-title>
            <source>Int Braz J Urol</source>
            <year>2022</year>
            <season>Sep-Oct</season>
            <volume>48</volume>
            <issue>5</issue>
            <fpage>771</fpage>
            <page-range>771-781</page-range>
            <pub-id pub-id-type="pmid">35594328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Majeed</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Olang</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gorantla</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gluschitz</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Fournier's Gangrene Diagnosis and Treatment: A Systematic Review.</article-title>
            <source>Cureus</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>13</volume>
            <issue>10</issue>
            <fpage>e18948</fpage>
            <pub-id pub-id-type="pmid">34815897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schneidewind</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Anheuser</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;nburg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wagenlehner</surname>
                <given-names>FME</given-names>
              </name>
              <name>
                <surname>Kranz</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Hyperbaric Oxygenation in the Treatment of Fournier's Gangrene: A Systematic Review.</article-title>
            <source>Urol Int</source>
            <year>2021</year>
            <volume>105</volume>
            <issue>3-4</issue>
            <fpage>247</fpage>
            <page-range>247-256</page-range>
            <pub-id pub-id-type="pmid">33285541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Capelli-Schellpfeffer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gerber</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>The use of hyperbaric oxygen in urology.</article-title>
            <source>J Urol</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>162</volume>
            <issue>3 Pt 1</issue>
            <fpage>647</fpage>
            <page-range>647-54</page-range>
            <pub-id pub-id-type="pmid">10458334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saifee</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Magaret</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Hess</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Delaney</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>O'Keefe</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Pham</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Foy</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bulger</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pagano</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Outcomes in necrotizing soft tissue infections treated with therapeutic plasma exchange.</article-title>
            <source>Transfusion</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>57</volume>
            <issue>6</issue>
            <fpage>1407</fpage>
            <page-range>1407-1413</page-range>
            <pub-id pub-id-type="pmid">28266045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Norrby-Teglund</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Muller</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Mcgeer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gan</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Guru</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bohnen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thulin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach.</article-title>
            <source>Scand J Infect Dis</source>
            <year>2005</year>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>166</fpage>
            <page-range>166-72</page-range>
            <pub-id pub-id-type="pmid">15849047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laor</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Tolia</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Winter</surname>
                <given-names>HI</given-names>
              </name>
            </person-group>
            <article-title>Outcome prediction in patients with Fournier's gangrene.</article-title>
            <source>J Urol</source>
            <year>1995</year>
            <month>Jul</month>
            <volume>154</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <page-range>89-92</page-range>
            <pub-id pub-id-type="pmid">7776464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yilmazlar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ozturk</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ozguc</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ercan</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Vuruskan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Oktay</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Fournier's gangrene: an analysis of 80 patients and a novel scoring system.</article-title>
            <source>Tech Coloproctol</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>217</fpage>
            <page-range>217-23</page-range>
            <pub-id pub-id-type="pmid">20559857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roghmann</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>von Bodman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>L&#x000f6;ppenberg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hinkel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Palisaar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Noldus</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Is there a need for the Fournier's gangrene severity index? Comparison of scoring systems for outcome prediction in patients with Fournier's gangrene.</article-title>
            <source>BJU Int</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>110</volume>
            <issue>9</issue>
            <fpage>1359</fpage>
            <page-range>1359-65</page-range>
            <pub-id pub-id-type="pmid">22494217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>XD</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>[Different scoring systems to evaluate the prognosis of Fournier's gangrene: A comparative study].</article-title>
            <source>Zhonghua Nan Ke Xue</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>21</volume>
            <issue>8</issue>
            <fpage>720</fpage>
            <page-range>720-3</page-range>
            <pub-id pub-id-type="pmid">26442300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bayrak</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Erturhan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Borazan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Koc</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>Is hemoglobin A1c level effective in predicting the prognosis of Fournier gangrene?</article-title>
            <source>Urol Ann</source>
            <year>2016</year>
            <season>Jul-Sep</season>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>343</fpage>
            <page-range>343-7</page-range>
            <pub-id pub-id-type="pmid">27453658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolach</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>MacDermott</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>deVere White</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Treatment and complications of Fournier's gangrene.</article-title>
            <source>Br J Urol</source>
            <year>1989</year>
            <month>Sep</month>
            <volume>64</volume>
            <issue>3</issue>
            <fpage>310</fpage>
            <page-range>310-4</page-range>
            <pub-id pub-id-type="pmid">2804566</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Czymek</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kujath</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bruch</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Pfeiffer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nebrig</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seehofer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Guckelberger</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Treatment, outcome and quality of life after Fournier's gangrene: a multicentre study.</article-title>
            <source>Colorectal Dis</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>15</volume>
            <issue>12</issue>
            <fpage>1529</fpage>
            <page-range>1529-36</page-range>
            <pub-id pub-id-type="pmid">24034257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21939.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Theiss</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hofmockel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Eckert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Frohm&#x000fc;ller</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>[Cosmetic and functional long-term outcome after operation of Fournier gangrene].</article-title>
            <source>Urologe A</source>
            <year>1996</year>
            <month>Jul</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>338</fpage>
            <page-range>338-41</page-range>
            <pub-id pub-id-type="pmid">8928365</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
